Drug Shortage Report for AURO-QUETIAPINE
| Report ID | 129781 |
| Drug Identification Number | 02390205 |
| Brand name | AURO-QUETIAPINE |
| Common or Proper name | Quetiapine |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | QUETIAPINE |
| Strength(s) | 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500s |
| ATC code | N05AH |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2020-12-04 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2021-01-11 |
| Shortage status | Resolved |
| Updated date | 2021-01-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2021-01-15 | French | Compare |
| v6 | 2021-01-15 | French | Compare |
| v5 | 2021-01-15 | English | Compare |
| v4 | 2020-12-24 | French | Compare |
| v3 | 2020-12-24 | English | Compare |
| v2 | 2020-12-07 | French | Compare |
| v1 | 2020-12-07 | English | Compare |
Showing 1 to 7 of 7